These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 26847180)

  • 1. Molecular insights into the premature aging disease progeria.
    Vidak S; Foisner R
    Histochem Cell Biol; 2016 Apr; 145(4):401-17. PubMed ID: 26847180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes.
    Kreienkamp R; Croke M; Neumann MA; Bedia-Diaz G; Graziano S; Dusso A; Dorsett D; Carlberg C; Gonzalo S
    Oncotarget; 2016 May; 7(21):30018-31. PubMed ID: 27145372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of lamins and mutations of LMNA gene in physiological and premature aging].
    Sliwińska MA
    Postepy Biochem; 2007; 53(1):46-52. PubMed ID: 17718387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards delineating the chain of events that cause premature senescence in the accelerated aging syndrome Hutchinson-Gilford progeria (HGPS).
    Dreesen O
    Biochem Soc Trans; 2020 Jun; 48(3):981-991. PubMed ID: 32539085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
    Finley J
    Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hutchinson-Gilford progeria syndrome through the lens of transcription.
    Prokocimer M; Barkan R; Gruenbaum Y
    Aging Cell; 2013 Aug; 12(4):533-43. PubMed ID: 23496208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hutchinson-Gilford Progeria Syndrome: A premature aging disease caused by LMNA gene mutations.
    Gonzalo S; Kreienkamp R; Askjaer P
    Ageing Res Rev; 2017 Jan; 33():18-29. PubMed ID: 27374873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hutchinson-Gilford Progeria Syndrome: Challenges at Bench and Bedside.
    Kreienkamp R; Gonzalo S
    Subcell Biochem; 2019; 91():435-451. PubMed ID: 30888661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a mini-review.
    Arancio W; Pizzolanti G; Genovese SI; Pitrone M; Giordano C
    Gerontology; 2014; 60(3):197-203. PubMed ID: 24603298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody.
    McClintock D; Gordon LB; Djabali K
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2154-9. PubMed ID: 16461887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome.
    Harhouri K; Frankel D; Bartoli C; Roll P; De Sandre-Giovannoli A; Lévy N
    Nucleus; 2018 Jan; 9(1):246-257. PubMed ID: 29619863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture.
    Rivera-Torres J; Acín-Perez R; Cabezas-Sánchez P; Osorio FG; Gonzalez-Gómez C; Megias D; Cámara C; López-Otín C; Enríquez JA; Luque-García JL; Andrés V
    J Proteomics; 2013 Oct; 91():466-77. PubMed ID: 23969228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome.
    Liu GH; Barkho BZ; Ruiz S; Diep D; Qu J; Yang SL; Panopoulos AD; Suzuki K; Kurian L; Walsh C; Thompson J; Boue S; Fung HL; Sancho-Martinez I; Zhang K; Yates J; Izpisua Belmonte JC
    Nature; 2011 Apr; 472(7342):221-5. PubMed ID: 21346760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of nuclear F-actin formation and its relevance to cellular phenotypes in Hutchinson-Gilford progeria syndrome.
    Takahashi Y; Hiratsuka S; Machida N; Takahashi D; Matsushita J; Hozak P; Misteli T; Miyamoto K; Harata M
    Nucleus; 2020 Dec; 11(1):250-263. PubMed ID: 32954953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progerin impairs chromosome maintenance by depleting CENP-F from metaphase kinetochores in Hutchinson-Gilford progeria fibroblasts.
    Eisch V; Lu X; Gabriel D; Djabali K
    Oncotarget; 2016 Apr; 7(17):24700-18. PubMed ID: 27015553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome.
    Capell BC; Erdos MR; Madigan JP; Fiordalisi JJ; Varga R; Conneely KN; Gordon LB; Der CJ; Cox AD; Collins FS
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12879-84. PubMed ID: 16129833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition.
    Glynn MW; Glover TW
    Hum Mol Genet; 2005 Oct; 14(20):2959-69. PubMed ID: 16126733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truncated prelamin A expression in HGPS-like patients: a transcriptional study.
    Barthélémy F; Navarro C; Fayek R; Da Silva N; Roll P; Sigaudy S; Oshima J; Bonne G; Papadopoulou-Legbelou K; Evangeliou AE; Spilioti M; Lemerrer M; Wevers RA; Morava E; Robaglia-Schlupp A; Lévy N; Bartoli M; De Sandre-Giovannoli A
    Eur J Hum Genet; 2015 Aug; 23(8):1051-61. PubMed ID: 25649378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced nuclear protein export in premature aging and rescue of the progeria phenotype by modulation of CRM1 activity.
    García-Aguirre I; Alamillo-Iniesta A; Rodríguez-Pérez R; Vélez-Aguilera G; Amaro-Encarnación E; Jiménez-Gutiérrez E; Vásquez-Limeta A; Samuel Laredo-Cisneros M; Morales-Lázaro SL; Tiburcio-Félix R; Ortega A; Magaña JJ; Winder SJ; Cisneros B
    Aging Cell; 2019 Oct; 18(5):e13002. PubMed ID: 31305018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the phospholipase A2 receptor ameliorates premature aging phenotypes.
    Griveau A; Wiel C; Le Calvé B; Ziegler DV; Djebali S; Warnier M; Martin N; Marvel J; Vindrieux D; Bergo MO; Bernard D
    Aging Cell; 2018 Dec; 17(6):e12835. PubMed ID: 30216637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.